Masamichi Sugimori - Concepedia

Author

Masamichi Sugimori

Daiichi University of Pharmacy

Also Known As

M. SUGIMORI, Masamichi SUGIMORI, Masamichi Sugimori

Publications

557

Citations

H-Index

Concepts

All Affiliations

Daiichi University of Pharmacy The University of Tokyo Daiichi-Sankyo (Japan)

About

Masamichi Sugimori is an author at Daiichi University of Pharmacy specializing in pharmacology, drug discovery, and chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	185
2	Natural Sciences	6	6	200
3	Engineering	5	5	117
4	Biochemistry	4	4	151
5	Biomolecular Engineering	4	4	96

Masamichi Sugimori

Publications

546

Citations

H-Index

Page 1

	Year	Citations
A New Water‐soluble Camptothecin Derivative, DX‐8951f, Exhibits Potent Antitumor Activity against Human Tumors <i>in vitro</i> and <i>in vivo</i> Ikuo Mitsui, Eiji Kumazawa, Yasuhide Hirota, Japanese Journal of Cancer Research	1995	160
Antitumor Agents. VII. Synthesis and Antitumor Activity of Novel Hexacyclic Camptothecin Analogs Masamichi Sugimori, Akio Ejima, Satoru Ohsuki, Journal of Medicinal Chemistry Hexacyclic Ring SystemMedicinal ChemistryPharmaceutical ScienceAntitumor ActivityHexacyclic Compounds	1994	47
Antitumour agents. Part 2. Asymmetric synthesis of (S)-camptothecin Akio Ejima, Hirofumi Terasawa, Masamichi Sugimori, Journal of the Chemical Society Perkin Transactions 1 Inorganic ChemistryChemical ThermodynamicsEngineeringBiochemistryPhysicochemical Analysis	1990	44
Asymmetric synthesis of (S)-camptothecin Akio Ejima, Hirofumi Terasawa, Masamichi Sugimori, Tetrahedron Letters Synthetic ChemistryAsymmetric SynthesisBiochemistry	1989	43
Synthesis and Antitumor Activity of Ring A- and F-Modified Hexacyclic Camptothecin Analogues Masamichi Sugimori, Akio Ejima, Satoru Ohsuki, Journal of Medicinal Chemistry Bioorganic ChemistryAntitumor ActivityF-modified Hexacyclic AnaloguesOrganic ChemistryPharmacotherapy	1998	40
Synthesis and Antitumor Activity of Novel Pyrimidinyl Pyrazole Derivatives. II. Optimization of the Phenylpiperazine Moiety of 1-[5-Methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-3-phenylpiperazinyl-1-trans-propenes. Hiroyuki Naito, Satoru Ohsuki, Masamichi Sugimori, Chemical and Pharmaceutical Bulletin Antitumor ActivityOrganic ChemistryPharmacotherapyChemistryHeterocycle Chemistry	2002	37
Synthesis and Antitumor Activity of Novel Pyrimidinyl Pyrazole Derivatives. Hiroyuki Naito, Masamichi Sugimori, Ikuo Mitsui, Chemical and Pharmaceutical Bulletin	1999	28
Novel resolution of the anthracyclinone intermediate by the use of (2r, 3r)-(+)- and (2s, 3s)-(-).1,4-bis(4-chlorobenzyloxy)butane-2,3-diol K. TAMOTO, Masamichi Sugimori, Shiro Terashima Tetrahedron EngineeringHeterocyclicOrganic ChemistryNovel ResolutionChemistry	1984	27
Antitumor Agents. V. Synthesis and Antileukemic Activity of E-Ring-Modified (RS)-Camptothecin Analogues. Akio Ejima, Masamichi Sugimori, Satoru Ohsuki, Chemical and Pharmaceutical Bulletin Chemoprevention StrategyPharmacotherapyPharmaceutical ChemistryMedicinal ChemistryAntitumor Agents	1992	25
Antitumor Agents. VI. Synthesis and Antitumor Activity of Ring A-, Ring B-, and Ring C-Modified Derivatives of Camptothecin Hirofumi Terasawa, Masamichi Sugimori, Akio Ejima, Heterocycles Antitumor ActivityChemoprevention StrategyHeterocycle ChemistryPharmaceutical ChemistryMolecular Pharmacology	1994	21

Page 1